685121-45-3Relevant academic research and scientific papers
Design, synthesis and structure-activity evaluation of novel 2-pyridone-based inhibitors of α-synuclein aggregation with potentially improved BBB permeability
Díaz-de-Villegas, María D.,Gálvez, José A.,José Galano-Frutos, Juan,Mahía, Alejandro,Navarro, Susanna,Pallarés, Irantzu,Pe?a-Díaz, Samuel,Pujols, Jordi,Sancho, Javier,Ventura, Salvador
, (2021/11/16)
The treatment of Parkinson's disease (PD), the second most common neurodegenerative human disorder, continues to be symptomatic. Development of drugs able to stop or at least slowdown PD progression would benefit several million people worldwide. SynuClea
